Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma

Cancer

Volumn 95, Issue 1, 2002, Pages 47-53

  Igarashi, Hiroshi ^a   Esumi, Mariko ^a   Ishida, Hajime ^a   Okada, Kiyoki ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Loss of heterozygosity (LOH); Microsatellite; Mutation; Overexpression; Renal cell carcinoma (RCC); Restriction enzyme fragment length polymorphism; Single nucleotide polymorphism; Tumor suppressor gene; Vascular endothelial growth factor (VEGF)

Indexed keywords

DNA; MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ALLELISM; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENE INACTIVATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC POLYMORPHISM; HETEROZYGOSITY LOSS; HUMAN; KIDNEY CARCINOMA; MALE; MICROSATELLITE MARKER; NORTHERN BLOTTING; POLYMORPHIC LOCUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; TUMOR SUPPRESSOR GENE; VHL GENE; VON HIPPEL LINDAU DISEASE;

ADULT; AGED; CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; KIDNEY NEOPLASMS; LIGASES; LOSS OF HETEROZYGOSITY; LYMPHOKINES; MALE; MIDDLE AGED; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0036645598     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.10635     Document Type: Article

References (29)

1. Identification of the von Hippel-Lindau disease tumor suppressor gene
2. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma
3. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas
4. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma
5. Mutations of the VHL gene in sporadic renal cell carcinoma: Definition of a risk factor for VHL patients to develop an RCC
6. Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene in sporadic renal cell carcinoma
7. The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix
8. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal
9. Rbxl, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase
10. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
11. Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function
12. Ubiquitination of hypoxiainducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein [see comments]
13. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity
14. Activation of Sp1-mediated vascular permeability factor/vascular endothelial growth factor transcription requires specific interaction with protein kinase C zeta
15. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein
16. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and CUl2
17. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma
18. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas
19. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis
20. Vascular endothelial growth factor expression is increased in renal cell carcinoma
21. Inverse regulation of vascular endothelial growth factor and VHL tumor suppressor gene in sporadic renal cell carcinomas is correlated with vascular growth: An in vivo study on 29 tumors
22. Mutations of the VHL tumour suppressor gene in renal carcinoma
23. A PCR generated AccI RFLP in the 3′ untranslated region of the von Hippel-Lindau disease (VHL) tumour suppressor gene
24. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines
25. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
26. Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex
27. Activation of HIF1alpha ubiquitination by a reconstituted von hippel-lindau (VHL) tumor suppressor complex